"At the International Heart Institute of Montana, we bring together an expert team of cardiologists, heart surgeons, nurses and others to perform advanced cardiac procedures and search for new and improved ways to treat heart disease. Founded in 1995, we have clinics throughout Western Montana, including Missoula, Hamilton and Butte and are staffed by physicians and other care providers from Providence St. Patrick Hospital and the University of Montana. Our physicians travel to other communities to help maintain heart health across the region. Our staff understands that families and loved ones have unique needs and concerns and are an important part of the healing process."

During the past decade, International Heart Institute of Montana conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 3 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "International Heart Institute of Montana" #1 sponsor was "Abbott Medical Devices" with 2 trials, followed by "Biosite" with 2 trials sponsored, "Gilead Sciences" with 2 trials sponsored, "Yale University" with 2 trials sponsored and "Eisai Inc." with 2 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "International Heart Institute of Montana" #1 collaborator was "National Heart, Lung, and Blood Institute (NHLBI)" with 2 trials as a collaborator and "Saint Patrick Hospital" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "International Heart Institute of Montana" are "Acute Myocardial Infarction" (2 trials), "COVID-19" (2 trials), "Heart Failure" (2 trials), "Acute Kidney Injury" (1 trials) and "Cardiomyopathy" (1 trials). Many other conditions were trialed in "International Heart Institute of Montana" in a lesser frequency.

Most popular intervention types in "International Heart Institute of Montana" are "Drug" (4 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Remdesivir" (2 trials), "Standard of Care" (2 trials), "AQUAVAN® (fospropofol disodium) Injection" (1 trials), "CRT-D System" (1 trials) and "MitraClip System" (1 trials). Other intervention names were less common.

The vast majority of trials in "International Heart Institute of Montana" are 10 trials for "All" genders.

Currently, there are NaN active trials in "International Heart Institute of Montana". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in International Heart Institute of Montana, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in International Heart Institute of Montana, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".